, Tracking Stock Market Picks
Enter Symbol:

up 35.50 %

INSULET CORPORATION (PODD) rated Outperform with price target $26 by Northland Securities

Posted on: Friday,  Sep 7, 2012  8:25 AM ET by Northland Securities

Northland Securities rated Outperform INSULET CORPORATION (NASDAQ: PODD) on 09/07/2012, when the stock price was $21.66. Since
then, INSULET CORPORATION has gained 35.50% as of 01/11/2016's recent price of $29.35.
If you would have followed this Northland Securities's recommendation on PODD, you would have gained 35.5% of your investment in 1221 days.

Insulet Corporation is a medical device company that develops, manufactures and markets insulin infusion system for people with insulin-dependent diabetes. The Company?s OmniPod Insulin Management System (OmniPod System) consists of its OmniPod disposable insulin infusion device and its handheld, wireless Personal Diabetes Manager. The United States Food and Drug Administration have approved the OmniPod System for sale in the United States.

Our equity research effort attempts to identify high potential small-cap investment ideas. We offer traditional sell-side research services with a particular focus on unearthing information that either supports or challenges our investment thesis. We strive to continuously provide our institutional client base with timely and insightful thinking.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/7/2012 8:25 AM Buy
21.66 26.00
as of 12/31/2012
1 Week down  -0.09 %
1 Month down  -3.32 %
3 Months down  -1.66 %
1 YTD down  -2.03 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy